4
Changes in Ownership
TScan Therapeutics, Inc. Filed Acc 0000899243-21-035442
Chief Executive Officer bought 11,000 shares at $8.73 ($96,066)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SOUTHWELL DAVID P Chief Executive Officer | 2021-09-08 | Purchase | +11,000 | $8.73 | $96,066 | 97,899 | D |
| Open-market purchases · 11,000 sh · avg $8.73 · $96,066 | |||||||
Loading xslF345X03/doc4.xml…